Peters L, Laut K, Resnati C, Del Campo S, Leen C, Falconer K, Trofimova T, Paduta D, Gatell J, Rauch A, Lacombe K, Domingo P, Chkhartishvili N, Zangerle R, Matulionyte R, Mitsura V, Benfield T, Zilmer K, Khromova I, Lundgren J, Rockstroh J, Mocroft A, EuroSIDA Study Group.

Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals.

AIDS 2018. 32(14): 1995-2004. Nº de citas: 17

[doi:10.1097/QAD.0000000000001928]

Gol-Montserrat, Jordi, del Llano, Juan E., del Amo, Julia, Campbell, Colin, Navarro, Gemma, Segura, Ferran, Suarez, Ignacio, Teira, Ramon, Branas, Fatima, Serrano-Villar, Sergio, Moreno, Santiago, Morillo, Ramon, Fernandez, Elvira, Paz Marco, Ma, Blanch, Jordi, Castano, Manuel, Pujol, Ferran, Jose Fuster, Ma, Sebastian Hernandez, Juan, Garcia-Goni, Manuel, Nuno-Solinis, Roberto, Elizondo, Nerea.

HIV in Spain 2017: policies for a new management of chronicity beyond virological control

REVISTA ESPANOLA DE SALUD PUBLICA 2018. 92: . Nº de citas: 3

Del Amo J, Campbell C, Navarro G, Segura F, Suárez I, Teira R, Brañas F, Serrano-Villar S, Moreno S, Morillo R, Román I, Marrugat J, Fernández E, Marco MP, Blanch J, Castaño M, Pujol F, Fuster MJ, Hernández JS, García-Goñi M, Nuño-Solinís R, Elizondo N, Nuño-Solinís JEDL, Gol-Montserrat J.

VIH en España 2017: políticas para una nueva gestión de la cronicidad más allá del control virológico.

REVISTA ESPANOLA DE SALUD PUBLICA 2018. 92: .

Álvarez Cabo D, Alemany A, Martínez Sesmero JM, Moreno Guillén S.

Healthcare and economic impact.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 2018. 36 Suppl 1: 19-25.

[doi:10.1016/S0213-005X(18)30242-8]

Moreno S, Berenguer J, Fuster-Ruizdeapodaca MJ, García Ontiveros M.

Early diagnosis.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 2018. 36 Suppl 1: 35-39.

[doi:10.1016/S0213-005X(18)30245-3]

Portocarrero Nuñez JA, Gonzalez-Garcia J, Berenguer J, Gallego MJV, Loyarte JAI, Metola L, Bernal E, Navarro G, Del Amo J, Jarrín I.

Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients.

Medicine 2018. 97(38): . Nº de citas: 4

[doi:10.1097/MD.0000000000012238]

Cobo J.

A comprehensive approach for the patient with Clostridium difficile infection.

REVISTA ESPANOLA DE QUIMIOTERAPIA 2018. 31 Suppl 1: 27-31.

Pérez-Valero I, Pasquau J, Rubio R, Rivero A, Santos J, Sanz J, Mariño A, Crespo M, Hernández-Quero J, Iribarren JA, Gutiérrez F, Terrón A, Esteban H, Pérez-Molina JA.

Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2018. 73(9): 2444-2451. Nº de citas: 5

[doi:10.1093/jac/dky212]

Correa-Rocha R, Lopez-Abente J, Gutierrez C, Pérez-Fernández VA, Prieto-Sánchez A, Moreno-Guillen S, Muñoz-Fernández MÁ, Pion M.

CD72/CD100 and PD-1/PD-L1 markers are increased on T and B cells in HIV-1+ viremic individuals, and CD72/CD100 axis is correlated with T-cell exhaustion.

Plos One 2018. 13(8): . Nº de citas: 16

[doi:10.1371/journal.pone.0203419]

Rivero, Antonio, Polo, Rosa, Lopez Aldeguer, Jose, Lozano, Fernando, Antela, Antonio, Ramon Arribas, Jose, Asensi, Victor, Berenguer, Juan, Ramon Blanco, Jose, Luis Casado, Jose, Clotet, Bonaventura, Crespo, Manuel, Domingo, Pere, Duenas, Carlos, Maria Gatell, Jose, Luis Gomez-Sirvent, Juan, Gonzalez-Garcia, Juan, Antonio Iribarren, Jose, Bernaldo de Quiros, Juan Carlos Lopez, Lopez Cortes, Luis Fernando, Emilio Losa, Juan, Mallolas, Josep, Marino, Ana, Martinez, Esteban, Miro, Jose M., Moreno, Santiago, Palacios, Rosario, Pasquau, Juan, Antonio Pineda, Juan, Podzamczer, Daniel, Portilla, Joaquin, Poveda, Eva, Pulido, Federico, Rubio, Rafael, Santos, Jesus, Sanz Moreno, Jose, Sanz Sanz, Jesus, Jesus Tellez, Maria, de la Torre, Javier, Tuset, Montserrat, Perez Molina, Jose A..

Executive summary of the GESIDA/National AIDS Plan Consensus Document on Antiretroviral Therapy in Adults Infected by the Human Immunodeficiency Virus (Updated January 2017)

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 2018. 36(7): 435-445. Nº de citas: 2

[doi:10.1016/j.eimc.2017.04.001]

Salzer HJF, Stoney RJ, Angelo KM, Rolling T, Grobusch MP, Libman M, López-Vélez R, Duvignaud A, Ásgeirsson H, Crespillo-Andújar C, Schwartz E, Gautret P, Bottieau E, Jordan S, Lange C, Hamer DH, GeoSentinel Surveillance Network.

Epidemiological aspects of travel-related systemic endemic mycoses: a GeoSentinel analysis, 1997-2017.

JOURNAL OF TRAVEL MEDICINE 2018. 25(1): .

[doi:10.1093/jtm/tay055]

González-García A, Carpintero L, Fortún J, Navas-Elorza E, Martín-Dávila P, Moreno S.

Changes in tuberculosis in human immunodeficiency virus infected patients in a Spanish tertiary hospital (1995-2013).

REVISTA ESPANOLA DE QUIMIOTERAPIA 2018. 31(4): 329-335. Nº de citas: 1

Revell AD, Wang D, Perez-Elias MJ, Wood R, Cogill D, Tempelman H, Hamers RL, Reiss P, van Sighem AI, Rehm CA, Pozniak A, Montaner JSG, Lane HC, Larder BA, RDI Data and Study Group.

2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2018. 73(8): 2186-2196.

[doi:10.1093/jac/dky179]

Vázquez-Castellanos JF, Serrano-Villar S, Jiménez-Hernández N, Soto Del Rio MD, Gayo S, Rojo D, Ferrer M, Barbas C, Moreno S, Estrada V, Rattei T, Latorre A, Moya A, Gosalbes MJ.

Interplay between gut microbiota metabolism and inflammation in HIV infection.

ISME JOURNAL 2018. 12(8): 1964-1976. Nº de citas: 31

[doi:10.1038/s41396-018-0151-8]

Escolà-Vergé L, Rodríguez-Pardo D, Lora-Tamayo J, Morata L, Murillo O, Vilchez H, Sorli L, Carrión LG, Barbero JM, Palomino-Nicás J, Bahamonde A, Jover-Sáenz A, Benito N, Escudero R, Sampedro MF, Vidal RP, Gómez L, Corona PS, Almirante B, Ariza J, Pigrau C.

Candida periprosthetic joint infection: A rare and difficult-to-treat infection.

JOURNAL OF INFECTION 2018. 77(2): 151-157. Nº de citas: 11

[doi:10.1016/j.jinf.2018.03.012]

Blanco JR, Alejos B, Moreno S.

Impact of dolutegravir and efavirenz on immune recovery markers: results from a randomized clinical trial.

CLINICAL MICROBIOLOGY AND INFECTION 2018. 24(8): 900-907. Nº de citas: 9

[doi:10.1016/j.cmi.2017.11.016]

Cuypers L, Pérez AB, Chueca N, Aldamiz-Echevarría T, Alados JC, Martínez-Sapiña AM, Merino D, Pineda JA, Téllez F, Espinosa N, Salméron J, Rivero-Juarez A, Vivancos MJ, Hontañón V, Vandamme AM, García F.

Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis.

Plos One 2018. 13(7): . Nº de citas: 7

[doi:10.1371/journal.pone.0201268]

Fortún J, Gioia F, Muñoz P, Graus J, Gómez-García de la Pedrosa E, Martín-Dávila P, Saiz A, Vena A, Moreno S.

T2 magnetic resonance for the diagnosis of deep-seated invasive candidiasis in a liver recipient without candidemia.

REVISTA IBEROAMERICANA DE MICOLOGIA 2018. 35(3): 159-161.

[doi:10.1016/j.riam.2018.03.002]